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Introduction
We previously proposed a new paradigm to explain the role 
of autophagy in cancer metabolism.1,2 In this model, tumor 
cells secrete hydrogen peroxide, which induces oxidative stress 
in adjacent cancer-associated fibroblasts.3,4 Oxidative stress, 
in turn, drives the onset of autophagy in cancer-associated 
Senescent fibroblasts are known to promote tumor growth. However, the exact mechanism remains largely unknown. 
An important clue comes from recent studies linking autophagy with the onset of senescence. Thus, autophagy and 
senescence may be part of the same physiological process, known as the autophagy-senescence transition (AST). To test 
this hypothesis, human fibroblasts immortalized with telomerase (hTeRT-BJ1) were stably transfected with autophagy 
genes (BNIp3, CTSB or ATG16L1). Their overexpression was sufficient to induce a constitutive autophagic phenotype, 
with features of mitophagy, mitochondrial dysfunction and a shift toward aerobic glycolysis, resulting in L-lactate and 
ketone body production. Autophagic fibroblasts also showed features of senescence, with increased p21(WAF1/CIp1), a 
CDK inhibitor, cellular hypertrophy and increased β-galactosidase activity. Thus, we genetically validated the existence 
of the autophagy-senescence transition. Importantly, autophagic-senescent fibroblasts promoted tumor growth and 
metastasis, when co-injected with human breast cancer cells, independently of angiogenesis. Autophagic-senescent 
fibroblasts stimulated mitochondrial metabolism in adjacent cancer cells, when the two cell types were co-cultured, 
as visualized by MitoTracker staining. In particular, autophagic ATG16L1 fibroblasts, which produced large amounts of 
ketone bodies (3-hydroxy-butyrate), had the strongest effects and promoted metastasis by up to 11-fold. Conversely, 
expression of ATG16L1 in epithelial cancer cells inhibited tumor growth, indicating that the effects of autophagy are 
compartment-specific. Thus, autophagic-senescent fibroblasts metabolically promote tumor growth and metastasis, 
by paracrine production of high-energy mitochondrial fuels. Our current studies provide genetic support for the 
importance of “two-compartment tumor metabolism” in driving tumor growth and metastasis via a simple energy 
transfer mechanism. Finally, β-galactosidase, a known lysosomal enzyme and biomarker of senescence, was localized to 
the tumor stroma in human breast cancer tissues, providing in vivo support for our hypothesis. Bioinformatic analysis of 
genome-wide transcriptional profiles from tumor stroma, isolated from human breast cancers, also validated the onset of 
an autophagy-senescence transition. Taken together, these studies establish a new functional link between host aging, 
autophagy, the tumor microenvironment and cancer metabolism.
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fibroblasts, resulting in mitophagy, mitochondrial dysfunction 
and a shift toward aerobic glycolysis.5,6 Autophagy and mito-
chondrial dysfunction induces a catabolic state in cancer-asso-
ciated fibroblasts, resulting in the production of high-energy 
mitochondrial fuels (such as L-lactate, ketone bodies, gluta-
mine and free fatty acids).7 These mitochondrial fuels are then 
transferred to epithelial cancer cells to satisfy their high-energy 
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for a “lethal tumor microenvironment”.19 Thus, loss 
of stromal Cav-1 reflects its autophagic digestion 
by lysosomes, providing a sensitive biomarker for 
autophagy in the tumor stroma.5,6,19,23
Our current studies also provide new links 
between autophagy and senescence in cancer patho-
genesis. For example, it is now well-accepted that 
senescent fibroblasts promote tumor growth,24,25 but 
the mechanism(s) underlying this phenomenon,26 
and their physiological relevance, has remained 
elusive.
Autophagy and senescence may be part of the 
same biological phenomenon.27,28 In support of 
this notion, many of the same stimuli that induce 
autophagy (such as hydrogen peroxide and oxidative 
stress) also induce senescence,29,30 and myofibroblast 
differentation.31 This has implications for under-
standing the metabolic importance of cancer-associ-
ated myofibroblasts in tumor growth.
Interestingly, senescent fibroblasts show a pro-
gressive increase in lysosomal mass32-34 and a shift 
toward aerobic glycolysis.35,36 Thus, this senescence 
phenotype may be secondary to the induction of 
autophagy and mitophagy, resulting in mitochon-
drial dysfunction. In further support of this notion, 
β-galactosidase, an enzyme marker which is cur-
rently used as the gold standard for measuring the induction of 
senescence, is a known lysosomal enzyme.37 Other recent func-
tional studies also directly show that autophagic cells may be 
more sensitive to the induction of senescence.38-44
We suggest here that this process could be termed the 
“autophagy-senescence transition (AST)”, to better reflect that 
these two seemingly separate biological phenomena, may be part 
of a continuum.
In further support of this notion, here we demonstrate that 
genetically engineered autophagic fibroblasts, with tumor- and 
metastasis-promoting activity, also show many characteristics 
of senescence. Specifically, these autophagic-catabolic fibro-
blasts show increased expression of a CDK inhibitor [namely 
p21(WAF1/CIP1)], cellular hypertrophy (increased protein mass 
per cell) and elevated levels of β-galactosidase. Similarly, p21 
has been implicated in driving myofibroblast differentiation in 
cancer-associated fibroblasts45 as well as in the induction of both 
autophagy and senescence.46
In summary, stromal autophagy and senescence, which 
reflects catabolism in the tumor microenvironment, may meta-
bolically promote the anabolic growth of cancer cells. Thus, new 
approaches to target the autophagy-senescence transition could 
have important implications for preventing tumor growth and 
metastasis.
Since senescence is thought to reflect biological aging, our 
studies on autophagy-induced senescence may also explain why 
cancer incidence dramatically increases with advanced chrono-
logical age, by providing a “fertile soil” or metabolically permis-
sive catabolic microenvironment, to support the anabolic growth 
of “needy” cancer cells.14
demands, driving anabolic tumor growth.8 To take advantage of 
this increased fuel supply, cancer cells amplify their capacity for 
OXPHOS and oxidative mitochondrial metabolism.9,10 Thus, 
cancer cells and the tumor stroma are metabolically coupled, 
resulting in a form of “parasitic” cancer metabolism.7 We have 
termed this new paradigm (1) the “autophagic tumor stroma 
model of cancer”11-13 or more recently, (2) “two-compartment 
tumor metabolism”.14
This model has important clinical relevance, since protein 
biomarkers for autophagy and oxidative stress in the tumor 
stroma effectively predict early tumor recurrence, metastasis, 
drug-resistance and poor overall survival in human breast cancer 
patients.15-20 Similar results were also obtained with prostate can-
cer21 and melanoma patients,22 linking “two-compartment tumor 
metabolism” with metastasis.
Here, we set out to stringently test the “autophagic tumor 
stroma model of cancer”. We designed a functional genetic 
approach to validate the role of stromal autophagy in promot-
ing tumor growth and metastasis. For this purpose, we created a 
genetically tractable model using hTERT-immortalized human 
fibroblasts and MDA-MB-231 human breast cancer cells. This 
compartment-specific approach allowed us to genetically modify 
the capacity for either stromal fibroblasts or epithelial cancer cells 
to undergo autophagy and mitophagy. More specifically, we show 
that genetically engineered autophagic fibroblasts promote tumor 
growth and metastasis, while constitutive activation of autophagy 
in cancer cells effectively reduces tumor growth.
Importantly, these constitutively autophagic fibroblasts show a 
loss of Cav-1 protein expression, consistent with previous studies 
showing that a loss of stromal Cav-1 is a prognostic biomarker 
Figure 1. Fibroblasts overexpressing BNIp3 show a loss of Cav-1 expression, with 
constitutive activation of the autophagic program. BNIp3 was stably overexpressed 
in hTeRT fibroblasts via transduction with lenti-viral vectors. Lv-represents fibroblasts 
transduced with the vector-alone control, namely Lv-105 (puro). (A) Note that BNIp3 
overexpression in fibroblasts is sufficient to cause a dramatic reduction in caveolin-1 
(Cav-1) protein expression, seen by immunoblot analysis. (B) Similarly, BNIp3 over-
expression drives the upregulation of LC3-I and -II and cathepsin B, under basal cell 
culture conditions. (C) Overnight starvation drives even stronger expression of BNIp3, 
as well as Beclin1 and ATG16L1, which are other key markers of autophagy. Thus, BNIp3 
overexpression in fibroblasts is indeed sufficient to drive a loss of Cav-1 expression via 
the activation on an autophagic program. In all three panels, immunoblotting with 
β-actin is shown as a control for equal protein loading.
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conditions. Furthermore, overnight starvation drives even stron-
ger expression of BNIP3 as well as Beclin1 and ATG16L1, which 
are other key markers of autophagy. Thus, BNIP3 overexpression 
in fibroblasts is indeed sufficient to drive a loss of Cav-1 expres-
sion via the activation on an autophagic program.
In support of our current findings, previous studies have dem-
onstrated that ectopic expression of BNIP3 is sufficient to trigger 
autophagy and mitophagy.52
Fibroblasts overexpressing BNIP3 enhance tumor growth 
without a measurable increase in angiogenesis. To assess the 
functional in vivo effects of BNIP3 overexpression in fibroblasts, 
we next employed a mouse xenograft model. MDA-MB-231 
breast cancer cells were co-injected with BNIP3 fibroblasts or 
vector-alone control fibroblasts into the flanks of athymic nude 
mice. Figure 2A shows that at 4 weeks post-injection, BNIP3 
fibroblasts promoted an ~2.1-fold increase in tumor growth, 
as compared with vector-alone control fibroblasts. However, 
Figure 2B shows no differences in tumor neo-vascularization. 
Therefore, we conclude that autophagic BNIP3 fibroblasts are 
sufficient to promote tumor growth without increased angio-
genesis, further validating a crucial role for autophagic stroma in 
tumor development.
BNIP3L and Beclin1 overexpression in fibroblasts drives a 
loss of Cav-1 expression, and promotes tumor growth. As men-
tioned above, BNIP3L and BNIP3 are members of the Bcl-2 
protein family. BNIP3L and BNIP3 are sufficient to initiate the 
autophagic process, even in the absence of nutrient and oxygen 
Results
Fibroblasts overexpressing BNIP3 show a loss of Cav-1 expres-
sion with constitutive activation of the autophagic program. 
BNIP3 and BNIP3L are two members of the BH3-only subfam-
ily of Bcl-2 family proteins; these proteins form stable homo-
dimeric complexes that localize to the outer membrane of the 
mitochondria after cellular stress. This promotes either apoptosis 
or the induction of autophagy and/or mitophagy.50
To evaluate the role of BNIP3 and stromal autophagy in tumor 
development, BNIP3 was stably overexpressed in hTERT fibro-
blasts. Figure 1A shows that BNIP3 overexpression in fibroblasts 
is sufficient to cause a marked reduction in caveolin-1 (Cav-1) 
protein expression. Importantly, loss of stromal Cav-1 expression 
predicts early tumor recurrence, metastasis, drug-resistance and 
poor overall clinical outcome in human breast cancer patients.16-20
Previous studies have shown that Cav-1 loss is mediated via 
lysosomal degradation, during autophagy.5,6,51 Consistent with 
this observation, Figure 1B and C show that BNIP3 overexpres-
sion drives the upregulation of LC3-I and -II and cathepsin B 
(key markers of autophagy and lysosomes) under basal cell culture 
Figure 2. Fibroblasts overexpressing BNIp3 promote tumor growth 
without a measurable increase in angiogenesis. To assess the functional 
in vivo effects of BNIp3 overexpression in fibroblasts, we employed a 
mouse xenograft model. Briefly, MDA-MB-231 breast cancer cells were 
co-injected with BNIp3 fibroblasts or vector-alone control fibroblasts, 
into the flanks of nude mice. n = 10 per experimental group. Lv-105 
represents fibroblasts transduced with the vector-alone control, namely 
Lv-105 (puro). (A) Note that at 4 weeks post-injection, BNIp3 fibroblasts 
promoted an ~2.1-fold increase in tumor growth. (B) However, no 
significant differences in tumor neo-vascularization were observed. 
Thus, autophagic BNIp3 fibroblasts are sufficient to drive tumor growth, 
without increased angiogenesis.
Figure 3. BNIp3L and Beclin1 overexpression in fibroblasts drives a loss 
of Cav-1 expression and promotes tumor growth. To investigate the in-
volvement of stromal BNIp3L and Beclin1 in tumor formation, we stably 
overexpressed both genes in hTeRT fibroblasts. Lv represents fibro-
blasts transduced with the vector-alone control, namely Lv-105 (puro). 
(A) Note that BNIp3L and Beclin1 overexpression in fibroblasts is suf-
ficient to induce a loss of Cav-1 expression, as observed by immunoblot 
analysis. Blotting with β-actin is shown as a control for equal protein 
loading. (B) BNIp3-, Beclin1- or control fibroblasts were co-injected with 
MDA-MB-231 epithelial breast cancer cells, into the flanks of nude mice. 
At 4 weeks post-injection, the mice were sacrificed, and the tumors 
were collected. n = 10 per experimental group. For both BNIp3L- and 
Beclin1 fibroblasts, a significant increase in tumor growth was observed. 
Thus, overexpression of both autophagic genes (BNIp3L and Beclin1) is 
sufficient to drive tumor growth.
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To investigate if stromal cathepsin B 
expression plays a significant functional 
role in breast cancer pathogenesis, we 
next overexpressed the CTSB gene in 
fibroblasts, via lenti-viral transduction. 
Note that both the CTSB-precursor and 
activated-cleaved form were observed by 
immunoblot analysis, in stably trans-
fected hTERT fibroblasts (Fig. 4A).
We also evaluated CTSB expression 
after nutrient starvation, a strong natu-
ral inducer of autophagy. Figure 4B 
shows that CTSB continued to accu-
mulate during starvation, consistent 
with its stabilization within lysosomes 
during autophagy. Thus, we next evalu-
ated Cav-1 expression after overnight 
starvation. As expected, we detected a 
strong reduction in Cav-1 protein levels 
(Fig. 4C), again validating the connec-
tion between autophagy induction and 
loss of Cav-1 protein expression.
Immunoblot analysis of CTSB fibro-
blasts demonstrated that cathepsin B 
overexpression is sufficient to drive 
the induction of autophagy. Indeed, 
Figure 4D shows that cathepsin B 
overexpression strongly induces several 
autophagy/mitophagy markers (BNIP3, 
Lamp1, Beclin1 and ATG16L1).
Finally, the in vivo functional effects 
of stromal CTSB were evaluated using a 
xenograft model. Briefly, MDA-MB-231 
cells were co-injected with CTSB fibroblasts or vector-alone con-
trol fibroblasts into the flanks of nude mice. Figure 5A shows 
that CTSB fibroblasts promoted a significant ~2.1-fold increase 
in tumor growth as compared with control fibroblasts. However, 
quantitation of neo-vascularization, via immunostaining with 
CD31, did not show any significant increases in tumor angiogen-
esis (Fig. 5B). Thus, autophagy in the tumor stroma can promote 
tumor growth independently of angiogenesis.
Fibroblasts overexpressing ATG16L1 show constitutive acti-
vation of the autophagic program and enhanced tumor growth. 
ATG16L1 is a key molecular component of a large protein com-
plex essential for autophagy.55 It specifically functions as a clath-
rin adaptor protein during autophagy, thereby facilitating the 
recruitment of plasma membrane, driving autophagosome for-
mation via endocytosis.56,57
To assess the functional role of stromal ATG16L1 in breast 
cancer development, we stably overexpressed ATG16L1 in 
hTERT-fibroblasts (Fig. 6A). We also analyzed the induction 
of a panel of autophagy and mitophagy markers. Figure 6B 
and C show that ATG16L1 overexpression induces the upregula-
tion of Beclin1 and Lamp1, under basal cell culture conditions. 
Similarly, increases in cathepsin B and LC3 were also observed 
after overnight starvation.
deprivation.53 Like BNIP3, the mechanism proposed for BNIP3L 
involves the ability of its BH3-domain to displace Beclin1 from 
the Bcl-2- or Bcl-X
L
-Beclin1 complexes. Beclin1 is then capable 
of triggering autophagy, since it is a key regulatory protein in 
phagophore formation.53
To investigate the involvement of stromal BNIP3L and 
Beclin1 in tumor formation, we stably overexpressed both genes 
in hTERT fibroblasts. Figure 3A shows that BNIP3L and Beclin1 
overexpression in fibroblasts is sufficient to induce a loss of Cav-1 
expression, as predicted.
In vivo studies were also performed to evaluate if BNIP3L and/
or Beclin1 overexpression affects tumor growth. BNIP3, Beclin1 
or control fibroblasts were co-injected with MDA-MB-231 epi-
thelial breast cancer cells into the flanks of nude mice. At 4 weeks 
post-injection, the mice were sacrificed, and the tumors were col-
lected. Figure 3B shows a significant increase in tumor growth of 
1.5- and 1.4-fold for BNIP3L and Beclin1, respectively.
Fibroblasts overexpressing cathepsin B (CTSB) show a loss of 
Cav-1 expression, with constitutive activation of the autophagic 
program, and enhanced tumor growth. Cathepsin B is a cysteine 
protease involved in autophagy that is located primarily within 
bona fide lysosomes and lysosome-like organelles, where it func-
tions in the degradation and/or processing of lysosomal proteins.54 
Figure 4. Fibroblasts overexpressing Cathepsin B (CTSB) show a loss of Cav-1 expression, with con-
stitutive activation of the autophagic program. (A) To investigate if stromal cathepsin B expression 
plays a significant functional role in breast cancer pathogenesis, we overexpressed the CTSB gene 
in fibroblasts, via lenti-viral transduction. Note that both the CTSB-precursor and activated-cleaved 
form were observed by immunoblot analysis, in stably transfected hTeRT fibroblasts. (B) Cathepsin B 
expression was also evaluated after 12 h and 16 h of starvation (in Hepes-buffered HBSS). Note that 
CTSB continued to accumulate during starvation, consistent with its stabilization within lysosomes, 
during autophagy. (C) We also evaluated Cav-1 expression after overnight starvation. As expected, 
we detected a strong reduction in Cav-1 protein levels, validating the connection between au-
tophagy and loss of Cav-1 protein expression. (D) Immunoblot analysis of CTSB fibroblasts demon-
strated that cathepsin B overexpression is sufficient to drive the induction of autophagy. Note that 
cathepsin B overexpression strongly induces several autophagy/mitophagy markers (BNIp3, Lamp1, 
Beclin1 and ATG16L1). In all panels, β-actin expression was assessed as a control for equal protein 
loading. Lv-represents fibroblasts transduced with the vector-alone control, namely Lv-105 (puro).
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fibroblasts into the tail vein of nude mice. Importantly, the lung 
colonization assay showed that all three autophagic fibroblast cell 
lines (BNIP3, CTSB and ATG16L1) enhanced the metastatic 
capacity of MDA-MB-231 cells as compared with vector-alone 
control fibroblasts (Fig. 10A). For example, BNIP3 fibroblasts 
and CTSB fibroblasts increased metastasis by ~2.5-fold and 
~7-fold, respectively. Interestingly, ATG16L1 fibroblasts showed 
the largest capacity for increasing metastasis, driving an ~11-fold 
increase. ATG16L1 fibroblasts also showed increases in myofi-
broblast markers, such as calponin and vimentin, indicating that 
autophagy may be also sufficient to promote myofibroblast dif-
ferentiation (Fig. 10B). Myofibroblasts may play a crucial role in 
metastasis.59
Consistent with our current findings, a previous study on 
human oral cancers showed that increased stromal expression of 
ATG16L1 was associated with both lympho-vascular invasion 
and lymph-node metastasis.60 However, the authors did not pro-
vide any mechanistic insights into the prognostic value of stromal 
ATG16L1 and its association with metastasis.
Autophagic fibroblasts show the induction of p21(WAF1/
CIP1), a CDK inhibitor, and characteristics of senescence: 
Cell hypertrophy and β-galactosidase activity. Autophagy has 
In vivo, ATG16L1-fibrolasts promoted tumor growth, result-
ing in an ~1.6-fold increase in tumor volume relative to control 
fibroblasts (Fig. 7A). Again, the increases observed in tumor 
growth were independent of tumor angiogenesis (Fig. 7B), as we 
previously observed for BNIP3 and CTSB.
BNIP3-, CTSB- and ATG16L1-expressing fibroblasts all 
show mitochondrial dysfunction with increased production of 
L-lactate or ketone bodies. Autophagy is a process that induces 
the degradation of several organelles, including mitochondria.58 
Therefore, we evaluated the functional consequences of autopha-
gic genes expression on mitochondrial activity in fibroblasts.
First, we determined the levels of mitochondrial enzymes 
associated with the respiratory chain. Figure 8A shows a strong 
reduction in key components of complex I, III and IV for all 
the genes examined. Furthermore, in CTSB fibroblasts there is a 
downregulation of the expression of complex II. These data were 
also corroborated by performing MitoTracker staining, which 
allows the vital visualization of healthy functional mitochon-
dria. Note that all three types of autophagic fibroblasts (BNIP3, 
CTSB and ATG16L1) show dramatic reductions in MitoTracker 
staining, indicative of a loss of mitochondrial membrane poten-
tial (Fig. 8B).
Loss of functional mitochondria is associated with key changes 
in cell metabolism, leading to the accumulation of L-lactate and/
or ketone bodies as end products in the tissue culture media. 
Figure 9A shows that BNIP3- and CTSB fibroblasts both 
increase L-lactate production, between 25%-to-37%. However, 
ATG16L1 fibroblasts did not show any increase in L-lactate 
accumulation.
Mitochondrial dysfunction can also activate ketone body 
production, resulting in the accumulation of 3-hydroxy-butyr-
ate. Interestingly, only ATG16L1 fibroblasts showed increases 
in ketone production, resulting in an up to 2.3-fold accumula-
tion of 3-hydroxy-butyrate (Fig. 9B and C). Thus, BNIP3 and 
CTSB fibroblasts produce L-lactate, while ATG16L1 fibroblasts 
produce ketone bodies, as a consequence of autophagy induction 
and resulting mitochondrial dysfunction.
Since both L-lactate and 3-hydroxy-butyrate are key substrates 
for mitochondrial oxidative metabolism, autophagic fibroblasts 
would be predicted to promote the mitochondrial activity of 
adjacent cancer cells in a paracrine fashion. To test this hypoth-
esis directly, autophagic fibroblasts were co-cultured with MDA-
MB-231-GFP cells, and mitochondrial activity was visualized by 
MitoTracker staining (Fig. 9D).
As predicted, all three fibroblast cell lines stably expressing 
autophagy inducers (BNIP3, CTSB and ATG16L1) increased the 
MitoTracker staining in adjacent MDA-MB-231 cells during co-
culture. This is consistent with the notion that autophagic fibro-
blasts may provide mitochondrial substrates, such as L-lactate 
and ketone bodies, for the anabolic growth of cancer cells.
Autophagic fibroblasts promote experimental metasta-
sis and lung colonization. Next, we investigated the ability of 
autophagic fibroblasts to increase the metastatic potential of epi-
thelial breast cancer cells. For this purpose, we used an experi-
mental metastasis approach, which measures lung colonization 
as an output. Briefly, MDA-MB-231 cells were co-injected with 
Figure 5. Fibroblasts overexpressing Cathepsin B (CTSB) drive en-
hanced tumor growth without a measurable increase in angiogenesis.
(A) The in vivo functional effects of stromal CTSB were evaluated 
using a xenograft model. MDA-MB-231 cells were co-injected with 
CTSB fibroblasts or vector-alone control fibroblasts into the flanks of 
nude mice. Note that CTSB fibroblasts promoted a significant ~2.1-fold 
increase in tumor growth, as compared with control fibroblasts. n = 10 
per experimental group. Lv-105 represents fibroblasts transduced with 
the vector-alone control, namely Lv-105 (puro). (B) Quantitation of neo-
vascularization, via immunostaining with CD31, did not show any sig-
nificant increases in tumor angiogenesis. Thus, autophagy in the tumor 
stroma can promote tumor growth independently of angiogenesis.
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response to constitutive protein degradation (via autophagy),62,63 
resulting in increased protein synthesis to avoid cell death.47
Finally, the induction of β-galactosidase activity is currently 
the gold standard for measuring the onset of senescence. Thus, 
we quantitatively measured the β-galactosidase activity of the 
autophagic fibroblast cell lines by FACS analysis. Figure 12B 
directly shows that all three autophagic fibroblast cell lines 
showed an increase in β-galactosidase activity, as reflected by an 
increase in (1) the % of β-Gal-positive cells (up to nearly 3-fold) 
and (2) β-Gal mean intensity (up to ~2.25-fold). Similar results 
were also obtained with more conventional β-Gal-staining meth-
ods, such as in BNIP3 overexpressing fibroblasts (Fig. 12C).
β-galactosidase is predominantly expressed in the tumor 
stroma of human breast cancer patients. We next investigated 
the possible compartmentalization of β-galactosidase in a panel 
of human breast cancer samples, largely derived from patients 
with a loss of stromal Cav-1 expression. Interestingly, our results 
directly show that, using specific antibodies directed against 
β-galactosidase, it is largely confined to the tumor stroma 
(Fig. 13). Thus, expression of β-galactosidase in vivo may be 
a stromal phenomenon, reflecting the onset of autophagy and 
senescence in the tumor stromal compartment. Further studies 
are warranted to assess the prognostic value of β-galactosidase as 
a new stromal biomarker for predicting clinical outcome of breast 
cancer patients.
also been linked to the induction of cellular senescence.27,61 In 
fact, autophagy and senescence may be viewed as a continuum 
of the same biological process. To begin to assess the induction 
of a senescence phenotype, we first examined the expression of 
CDKI’s (cyclin-dependent kinase inhibitors) and cyclin D1 in all 
three autophagic fibroblast cell lines. BNIP3 fibroblasts showed 
an induction of p21(WAF1/CIP1) and p16(Ink4a), without any 
changes in p19(ARF). Conversely, CTSB- and ATG16L1 fibro-
blasts showed an induction of p21 and p19, with reductions 
in p16. Thus, the most consistent change observed across all 
three autophagic fibroblast cell lines was the induction of p21 
(Fig. 11A).
Senescent cells also appear flatter and/or hypertrophic, as 
protein synthesis may continue without cell division. Indeed, we 
noted that BNIP3, CTSB and ATG16L1 fibroblasts all appeared 
more hypertrophic, as seen by light microscopy 72 h after cell 
plating (Fig. 11B). A more quantitative estimation of cell hyper-
trophy was achieved by measuring the total amount of protein 
per cell (Fig. 12A). Previously, studies have demonstrated that an 
increase in cell protein content is related to the induction of cell 
cycle arrest and senescence.47 Importantly, BNIP3 and ATG16L1 
fibroblasts both showed significant cell hypertrophy (between 
30%-to-32%), using this approach, while CTSB fibroblasts also 
demonstrated a trend toward cell hypertrophy. Increased protein 
mass per cell (hypertrophy) may simply reflect a compensatory 
Figure 6. Fibroblasts overexpressing ATG16L1 show constitutive activa-
tion of the autophagic program. (A) ATG16L1 functions as a clathrin 
adaptor protein during autophagy, facilitating the recruitment of plas-
ma membrane, by driving autophagosome formation via endocytosis. 
To assess the functional role of stromal ATG16L1 in breast cancer devel-
opment, we stably overexpressed ATG16L1 in hTeRT fibroblasts. (B) Note 
that ATG16L1 overexpression induces the upregulation of Beclin1 and 
Lamp1, under basal cell culture conditions. (C) Similarly, increases in 
cathepsin B and LC3 were also observed after overnight starvation (in 
Hepes-buffered HBSS). In all three panels, β-actin expression was as-
sessed as a control for equal protein loading. Lv represents fibroblasts 
transduced with the vector-alone control, namely Lv-105 (puro).
Figure 7. Fibroblasts overexpressing ATG16L1 drive enhanced tumor 
growth, without a measurable increase in angiogenesis. (A) In vivo, 
ATG16L1-fibrolasts also promoted tumor growth, resulting in an 
~1.6-fold increase in tumor volume, relative to control fibroblasts. 
n = 10 per experimental group. (B) Increases observed in tumor growth 
were independent of tumor angiogenesis, as we previously observed 
for BNIp3, and CTSB. Lv-105 represents fibroblasts transduced with the 
vector-alone control, namely Lv-105 (puro).
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genetically tractable models that we have created to study two-
compartment tumor metabolism.
Similarly, Table 2 shows a list of senescence-associated genes 
that are specifically upregulated in the tumor stroma of pri-
mary human breast cancers, including p21(WAF1/CIP1), p16 
(INK4A), cyclin D1/B1 and β-galactosidase. Upregulation of 
cyclin D1 and cyclin B1 may represent compensatory responses 
to cell cycle arrest. A more complete list of senescence-associated 
genes that are upregulated in the tumor stroma is included as 
Table S1 (Supplemental Data).
Thus, this data mining exercise provides additional in vivo 
evidence for the existence of the autophagy-senescence transi-
tion (AST) in the tumor microenvironment of human breast 
cancers.
Discussion
The role of autophagy in tumorigenesis is complex; its action 
may be compartment- and cell type-specific.23 Autophagy was 
originally linked to reduced tumor growth when Beclin1, a cru-
cial autophagy regulator, was first reported to be deleted in many 
epithelial cancers, indicating that autophagy can function as a 
tumor suppressor.64 In dramatic support of this simple concept, 
ATG16L1 expression in human breast cancer cells 
drives autophagy and reduces tumor growth. To under-
stand the compartment-specific role of autophagy in tumor 
growth, we also stably overexpressed ATG16L1 in human 
breast cancer cells. ATG16L1 overexpression in MDA-MB 
231 cells by itself is indeed sufficient to drive autophagy and 
mitophagy under baseline cell culture conditions, as evi-
denced by the loss of Cav-1 expression and the upregulation 
of BNIP3 (Fig. 14A and B). Similarly, Figure 14A and B 
show that MDA-MB 231 cells harboring ATG16L1 display 
the upregulation of certain autophagy markers (Beclin1 and 
CTSB) after overnight starvation.
Next, we evaluated the expression of key cell cycle regula-
tors: CDK inhibitors and cyclin D1. Figure 14C shows that 
ATG16L1 overexpression in MDA-MB-213 cells induces 
p21 expression but no significant changes were detected in 
p19 and/or Cyclin D1 protein levels.
Finally, we assessed the capacity of autophagic 
MDA-MD-231 cells to undergo tumor growth in vivo after 
implantation in the flanks of nude mice. Figure 14D shows 
that ATG16L1 overexpression caused a near 2-fold reduc-
tion in tumor volume. These “tumor suppressor” effects 
were independent of angiogenesis, since we did not observe 
any differences in tumor neo-vascularization, as assessed by 
quantitation of CD31-positive vessels (Fig. 14E).
Thus, the effects of autophagy on tumor cell growth are 
clearly cell type- and compartment-specific and may exert 
opposing effects depending in which cell type the autopha-
gic program is activated.
Validation of the autophagy-senescence transition 
(AST) by analysis of existing transcriptional profiles of 
laser-captured tumor stroma isolated from human breast 
cancer patient materials. Previously, Morag Park and col-
leagues48 laser-captured the normal stroma from human breast 
tissue (n = 38 patients) and the tumor stroma from human breast 
cancers (n = 53 patients). Then, they subjected these patient 
materials to genome-wide transcriptional profiling. Of the breast 
cancer patients analyzed (n = 53), a significant number of the 
patients analyzed underwent tumor recurrence (n = 11) or metas-
tasis (n = 25).
We retrieved these stromal transcriptional profiles from exist-
ing public databases49 and interrogated them for evidence of 
autophagy and/or senescence in the tumor stroma. These results 
are summarized briefly in Tables 1 and 2. p-values for these 
associations are as shown. Table 1 includes a list of autophagy-
associated genes that are selectively upregulated in the tumor 
stroma (relative to normal stroma). Note that many of these gene 
transcripts are also specifically upregulated in the tumor stroma 
of patients that subsequently underwent tumor recurrence and/
or metastatsis (relative to breast cancer patients that did not 
undergo recurrence or metastasis).
This genes list also includes many of the same genes that we 
functionally analyzed by recombinant expression in fibroblasts, 
such as ATG16L1, BNIP3, BNIP3L, Beclin1 and CTSB as well 
as hTERT. Importantly, this supporting bioinformatics data pro-
vides direct evidence for the physiological relevance of the new 
Figure 8. BNIp3-, CTSB- and ATG16L1-fibroblasts all show mitochondrial 
dysfunction: OXpHOS and MitoTracker. (A) We evaluated the functional 
consequences of autophagic genes expression on mitochondrial activity in 
fibroblasts by determining the levels of mitochondrial enzymes associated 
with the respiratory chain. Note that a strong reduction in key components of 
complex I, III and IV was observed for all the genes examined. Furthermore, 
in CTSB fibroblasts, there is a downregulation of the expression of complex II. 
Lv-represents fibroblasts transduced with the vector-alone control, namely 
Lv-105 (puro). (B) Note that all three types of autophagic fibroblasts (BNIp3, 
CTSB and ATG16L1) show dramatic reductions in MitoTracker staining, indica-
tive of a loss of mitochondrial membrane potential.
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However, just the opposite effects may be occurring in the 
tumor stromal microenvironment (Fig. 15). Thus, a catabolic 
tumor stroma, driven by autophagy in cancer-associated fibro-
blasts, could “energize” the anabolic growth of cancer cells by 
providing essential nutrients and mitochondrial fuels (L-lactate, 
ketones, glutamine and free fatty acids) in a paracrine fashion.2,69 
We have previously termed this hypothesis the “autophagic tumor 
stroma model of cancer metabolism”.2,7
More specifically, we have demonstrated that oncogene-
induced activation of H
2
O
2
 production in cancer cells drives 
recombinant expression of Beclin1 in epithelial cancer cells drives 
autophagy and effectively suppresses tumorigenesis.65
Similarly, deficiencies in other autophagy regulators have 
been linked to a pro-tumorigenic phenotype.66 More specifically, 
autophagy-deficient cancer cells show increased DNA dam-
age and genomic instability as well as increased ROS levels and 
oxidative stress.67 Several oncogenes have been shown to repress 
autophagy in cancer cells, supporting the overall idea that cata-
bolic processes might be suppressed in tumor cells in order to 
favor the accumulation of cell biomass.68
Figure 9. BNIp3-, CTSB- and ATG16L1-fibroblasts all show mitochondrial dysfunction, with increased production of L-lactate or ketone bodies. (A) Loss 
of functional mitochondrial causes changes in cell metabolism, leading to the accumulation of L-lactate. Note that BNIp3- and CTSB-fibroblasts both 
show significant increases in L-lactate production, between 25-to-37%. However, ATG16L1 fibroblasts did not show any increases in L-lactate accumu-
lation. (B and C) Mitochondrial dysfunction can also activate ketone body production, resulting in the accumulation of 3-hydroxy-butyrate. Note that 
only ATG16L1 fibroblasts showed increases in ketone production, resulting in an up to 2.3-fold accumulation of 3-hydroxy-butyrate. The data were 
normalized either for cell number or for protein content per well. Thus, BNIp3- and CTSB fibroblasts produce L-lactate, while ATG16L1 fibroblasts pro-
duce ketone bodies, as a consequence of autophagy and the resulting mitochondrial dysfunction. (D) Autophagic fibroblasts were co-cultured with 
MDA-MB-231-GFp cells, and mitochondrial activity was visualized by MitoTracker staining. Note that all three autophagic fibroblast cell lines (BNIp3, 
CTSB and ATG16L1) increased the MitoTracker staining (red, upper panels) in adjacent MDA-MB-231 cells (green, lower panels), during co-culture. This 
is consistent with the notion that autophagic fibroblasts provide mitochondrial fuels, such as L-lactate and ketone bodies, for the anabolic growth of 
cancer cells.
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On the other hand, activation of autophagy in cancer cells drives 
the consumption of cellular components and effectively reduces 
tumor growth in MDA-MB-231 cells harboring ATG16L1.
A loss of stromal Cav-1 expression, specifically in cancer-
associated fibroblasts, is a new important prognostic marker 
that predicts early tumor recurrence, lymph node metastasis 
and tamoxifen resistance, as well as poor clinical outcome in 
breast cancer patients.15-20 The proposed mechanism underly-
ing a loss of stromal Cav-1 in cancer-associated fibroblasts is that 
Cav-1 undergoes lysosomal degradation, due to the induction of 
autophagy, secondary to oxidative stress.5,6,23,51
Our current data mechanistically validated this hypothesis, 
as genetic induction of autophagy/mitophagy with numerous 
autophagy-associated genes was indeed sufficient to drive a loss 
of Cav-1 protein expression in fibroblasts. Thus, the autopha-
gic destruction of Cav-1 is biomarker for poor prognosis, as the 
autophagic tumor stroma provides recycled nutrients to fuel ana-
bolic tumor growth.
We also show that autophagy-induced mitochondrial dys-
function drives a shift toward glycolysis in stromal fibroblasts, 
with associated increases L-lactate or ketone body production. 
Remarkably, autophagic fibroblasts also promoted tumor cell 
metastasis, likely via the production of high-energy mitochon-
drial fuels, such as L-lactate and ketone bodies, which could be 
“burned” by OXPHOS in adjacent cancer cells. In this regard, 
ketogenic ATG16L1 fibroblasts showed the highest efficiency in 
promoting distant metastasis, resulting in an ~11-fold increase in 
lung colonization. Consistent with these findings, ketones are a 
more powerful mitochondrial fuel as compared with L-lactate. 
Ketones can produce more energy than L-lactate, as they require 
substantially less oxygen consumption and can be “burned” by 
oxidative stress in cancer-associated fibroblasts (CAFs), which 
then undergo autophagy and mitophagy.3,4,70 Loss of mitochon-
drial function increases aerobic glycolysis, driving the production 
and release of micro-nutrients, such as L-lactate and ketone bod-
ies into the tumor microenvironment.11,49,71-73
Ketones and L-lactate, in turn, can act by a paracrine mech-
anism on cancer cells, driving mitochondrial biogenesis and 
OXPHOS (oxidative phosphorylation) in tumor cells, gener-
ating a positive feed-forward loop to support anabolic tumor 
growth.9,10,74-76
Here, we developed a genetically tractable model system to 
directly study the compartment-specific role of autophagy in 
tumor growth and metastasis. First, we expressed autophagy-
associated genes (such as BNIP3, CTSB and ATG16L1) in 
hTERT-immortalized fibroblasts to genetically generate con-
stitutively autophagic fibroblasts. Then, we validated that these 
genetically modified fibroblasts undergo autophagy, mitophagy, 
develop significant mitochondrial dysfunction and metabolically 
shift toward glycolysis, with increased L-lactate and ketone body 
production. Importantly, these autophagic fibroblasts effectively 
promoted tumor growth and metastasis, mimicking the behavior 
of cancer-associated fibroblasts.
Interestingly, we demonstrated that overexpression of a single 
autophagy gene is sufficient to drive autophagy induction and 
promote tumor growth. Our study establishes that autophagy, 
by itself, is sufficient to enhance tumor growth, independently of 
neo-vascularization. Autophagy action is clearly compartment-
specific, since we also show that autophagy induction in human 
breast cancer cells greatly diminishes tumor growth. Thus, the 
induction of autophagy in stroma cells releases nutrients into the 
tumor microenvironment, which may support cancer cell growth. 
Figure 10. Autophagic fibroblasts promote experimental metastasis and lung colonization. (A) MDA-MB-231 cells were co-injected with fibroblasts 
into the tail vein of nude mice. Note that all three autophagic fibroblast cell lines (BNIp3, CTSB and ATG16L1) enhanced the metastatic capacity of MDA-
MB-231 cells, as compared with vector-alone control fibroblasts. BNIp3 fibroblasts and CTSB fibroblasts increased metastasis by ~2.5-fold and ~7-fold, 
respectively. Interestingly, ATG16L1 fibroblasts showed the largest capacity for increasing metastasis, driving an ~11-fold increase. (B) ATG16L1 fibro-
blasts also showed increases in myofibroblast markers, such as calponin and vimentin, indicating that autophagy may be also sufficient to promote 
myofibroblast differentiation. β-actin expression was assessed as a control for equal protein loading.
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rates remain high, primarily due to the metastasis of 
primary tumors to distant organs, such as the lungs.82 
In diabetic patients, it is possible that breast cancer 
metastasis may be augmented by metabolic dysfunc-
tion, such as a tendency toward ketone body produc-
tion. Although these data need to be confirmed with 
additional studies, they suggest that ketone bodies 
could play a crucial role in breast cancer metastasis.
Recently, several studies have linked autophagy with 
senescence. For example, ULK-3, a homolog of ATG1, 
induces autophagy in fibroblasts, conferring the acqui-
sition of a senescence phenotype.27,61 Another protein 
proposed as a link between autophagy and senescence is 
cathepsin B. More specifically, CTSB is able to proteo-
lytically cleave SIRT1, allowing for SIRT1 inactivation 
and driving the establishment of a senescence pheno-
type.83 Thus, autophagy and senescence may be viewed 
as a continuum or two related phases of the same overall 
biological process.
Our current results also directly support a molecular 
link between autophagy and senescence in the tumor 
stroma. For example, all the autophagic fibroblast 
cell lines we examined (overexpressing either BNIP3, 
CTSB or ATG16L1) showed key features of a senes-
cence phenotype, such as (1) induction of p21(WAF1/
CIP1), a well-characterized CDK inhibitor, (2) a 
change in cell shape, consistent with cellular hypertro-
phy and (3) the upregulation of β-galactosidase activ-
ity. To confirm the clinical relevance of our findings, 
we also examined the distribution of β-galactosidase 
in human breast cancers by immunohistochemistry, 
using specifc antibody probes. Interestingly, the dis-
tribution of β-galactosidase (and thus the senescence 
phenotype) was largely confined to the tumor stroma 
and absent from epithelial cancer cells. Thus, senes-
cence may be primarily confined to the tumor stromal 
compartment. Interestingly, β-galactosidase is also a 
known lysosomal enzyme and senescent cells show 
an increase in lysosomal mass,32,37 also supporting 
the general idea that senescence and autophagy are 
two sides of the same coin. Senescent cells also show a 
shift toward aerobic glycolysis,35,36 probably secondary 
to the onset of mitophagy.
Importantly, Judy Campisi’s group has previously shown that 
senescent fibroblasts promote tumor growth.24-26,84 Her laboratory 
attributed the growth-promoting activity of senescent fibroblasts 
to the senescence-associated secretory phenotype (SASP), which 
results in the secretion of specific growth factors and cytokines, 
as well as extracellular matrix remodeling.24,25 However, she 
estimated that the SASP accounts for only ~50% of the tumor-
promoting activity of senescent fibroblasts.24,25 The other 50% 
still remains unaccounted for.24,25 Importantly, many of the same 
stimuli that she used to generate senescent fibroblasts, such as 
acute exposure to hydrogen peroxide and oxidative stress, are now 
known to be inducers of autophagy, and are also inducers of myo-
fibroblast differentiation.29-31 Thus, we propose here that the other 
mitochondria under ischemic and/or hypoxic conditions.77,78 
Thus, there may be a direct connection between ketone body 
production/utilization and cancer cell metastasis.
Ketone bodies are a group of organic molecules are produced 
both in the cytosol and in mitochondria, which are always present 
at a low level in healthy individuals. However, dietary manipula-
tions and certain pathological conditions can increase the levels 
of these compounds in vivo. Pathologies leading to abnormal glu-
cose metabolism, such as poorly controlled diabetes mellitus, can 
drive increased ketone body production.79
Epidemiologic studies suggest that people suffering from 
diabetes are at a higher risk of many forms of cancer (including 
breast, colon, pancreas and etc.,) and diabetes is also associated 
with reduced survival after cancer.80,81 Breast cancer mortality 
Figure 11. Autophagic fibroblasts show the induction of p21(WAF1/CIp1), a CDK 
inhibitor and morphologic cell hypertrophy. (A) To assess the induction of a senes-
cence phenotype, we examined the expression of CDKI’s (cyclin-dependent kinase 
inhibitors) and cyclin D1, in all three autophagic fibroblast cell lines. BNIp3 fibro-
blasts showed an induction of p21(WAF/CIp1) and p16(Ink4a), without any changes 
in p19(ARF). Conversely, CTSB- and ATG16L1 fibroblasts showed an induction of 
p21 and p19, with reductions in p16. Thus, the most consistent change observed 
across all three autophagic fibroblast cell lines was the induction of p21. (B) Se-
nescent cells also appear flatter and/or hyper-trophic, as protein synthesis may 
continue without cell division. Note that BNIp3-, CTSB- and ATG16L1 fibroblasts all 
appear more hyper-trophic (“wider”), as seen by light microscopy 72 h after cell 
plating.
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target for “cutting off the fuel supply” to rapidly proliferating 
cancer cells that are energetically dependent on the tumor stroma.
Materials and Methods
Materials. Commercially available antibodies used were as fol-
lows: β-actin (Sigma-Aldrich, #A5441); Cav-1 (BD Transduction 
Laboratories, #610406); Beclin1 (Novus Biologicals, #NBP1-
00085); BNIP3 (Abcam, #ab10433); Cathepsin B (FL-339) 
(Santa Cruz, #sc-13985); Lamp-1 (E-5) (Santa Cruz, #sc-17768); 
LC3 (Abcam, ab48395); ATG16L1 (Abgent, #AP1817a); p21 
(H-164) (Santa Cruz, #sc-756); p19 (DCS-240) (Santa Cruz, 
50% of the tumor-promoting activity of senescent fibroblasts may 
actually reflect their autophagic/catabolic phenotype, mitochon-
drial dysfunction and a shift toward aerobic glycolysis, which 
results in production of mitochondrial fuels (such as L-lactate, 
ketones, glutamine and free-fatty acids). These mitochondrial 
fuels can then “feed” the TCA cycle and OXPHOS in adjacent 
cancer cells, allowing for the anabolic growth of tumor cells. In 
accordance with our new “metabolic” hypothesis, certain sub-
types of senescent fibroblasts promote tumor growth but do not 
show the senescence-associated secretory phenotype (SASP).26
Thus, inhibition of autophagy and senescence in cancer-asso-
ciated fibroblasts is now a new attractive metabolic therapeutic 
Figure 12. Autophagic fibroblasts show increased protein mass per cell, and the induction of β-galactosidase activity. (A) A quantitative view of cell 
hypertrophy was achieved by measuring the total amount of protein per cell. previously, it was demonstrated that an increase in cell protein content 
is related to the induction of senescence. Note that BNIp3- and ATG16L1 fibroblasts both showed significant cell hypertrophy (between 30-to-32%), 
using this approach, while CTSB fibroblasts also showed a trend toward cell hypertrophy. (B) β-galactosidase activity is the gold standard for measur-
ing the onset of senescence. Thus, we quantitatively measured β-galactosidase activity by FACS analysis. Note that all three autophagic fibroblast 
cell lines showed an increase in β-galactosidase activity, as reflected by an increase in (1) the % of β-Gal-positive cells and (2) β-Gal mean intensity. 
(C) Similar results were obtained with more conventional β-Gal-staining methods, such as in BNIp3-overexpressing fibroblasts.
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Figure 13. β-galactosidase is predominantly expressed in the tumor 
stroma of human breast cancer patients. We investigated the compart-
mentalization of β-galactosidase in a panel of human breast cancer 
samples, using specific-antibodies directed against β-galactosidase. 
Note that β-galactosidase is largely confined to the tumor stroma. Thus, 
expression of β-galactosidase in vivo may be a stromal phenomenon, 
reflecting the onset of senescence in the tumor microenvironment.
#sc-53639); p16 (H-156) (Santa Cruz, #sc-759); cyclin D1 
(Thermo Scientific, #MS-210); OXPHOS (MitoSciences, 
#MS601); Calponin 1/2/3 (FL-297) (Santa Cruz, #sc-28545); 
Vimentin (BD Pharmigen, #550513). Lentiviral vectors con-
taining full-length cDNAs encoding various autophagy genes 
(BNIP3, BNIP3L, Beclin1, CTSB and ATG16L1) were all 
obtained commercially from GeneCopoeia (Rockville, MD).
Cell culture. Immortalized human fibroblasts (hTERT-BJ1 
cells) and human breast cancer cells (MDA-MB-231-GFP), were 
cultured in DMEM implemented with 10% fetal bovine serum 
(FBS) and penicillin (100 units/mL)/streptomycin (100 μg/mL) 
(P/S). Hank’s Balanced salt solution (HBSS) supplemented with 
40 mM Hepes and 1% P/S was used to initiate cell starvation. 
For co-culture studies, hTERT fibroblasts and MDA-MB-231-
GFP cells were plated onto glass coverslips in 12-well plates in 
complete media at a cellular ratio of 5:1. The next day, the media 
was switched to DMEM supplemented with 10% NuSerum. 
Cells were maintained in co-culture for 3 d.
Lenti-virus production and cell line derivation. For lenti-
virus production, 293Ta cells were transfected with different 
plasmids, in particular, EX-neg-Lv105 (the empty vector con-
trol), EX-T1853-Lv105 (encoding BNIP3), EX-U0307-Lv105 
(encoding BNIP3L), EX-M0768-Lv105 (encoding Beclin1), 
EX-Z7498-Lv105 (encoding Beclin1), EX-5654-Lv105 (encod-
ing Cathepsin B), and EX-H2109-Lv105 (encoding ATG16L1). 
All plasmids also contained a puromycin resistance marker. The 
resulting lenti-viruses were then used to infect hTERT fibro-
blasts or MDA-MB-231-GFP cells to obtain stable cell lines 
overexpressing the target gene of interest.
Immunoblot analysis. Immunoblotting was performed on 
samples obtained through OG buffer extraction. For this pur-
pose, cells were scraped in OG lyses buffer (10 mM Tris, pH 
7.5, 150 mM NaCl, 1% Triton X-100 and 60 mM n-octyl-glu-
coside) supplemented with a protease inhibitor cocktail (Roche 
Diagnostics) and a phosphatase inhibitor cocktail (Sigma). The 
samples were rotated for 40 min, then centrifuged for 10 min at 
13,000x g at 4°C. Finally, supernatants were collected. To deter-
mine the expression of cell cycle-related proteins, the cells were 
scraped into RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl, 
1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, plus prote-
ase inhibitor and phosphatase inhibitor cocktails) and sonicated 
for 20 sec, then the samples were centrifuge 13,000x g for 10 
min at 4°C, and the supernatants were collected. The protein 
concentrations were determined using the BCA protein assay kit 
(Thermo scientific, #23225). Protein lysates were then separated 
by SDS-PAGE (using a 10-to-15% acrylamide gel) and trans-
ferred to nitrocellulose membranes. To detect expression of the 
protein of interest, specific primary antibodies and peroxidase-
conjugated secondary antibodies were used. Bound antibodies 
were revealed using enhanced chemiluminescence (ECL) sub-
strates (Thermo Scientific).
L-lactate assays. L-lactate levels were assessed according to the 
manufacturer’s instructions, using the EnzyChromTM L-Lactate 
Assay Kit (cat #ECLC-100, BioAssay Systems). For this purpose, 
cells were seeded in 12-well plates in complete media. The next 
day, the media was switched to DMEM containing 2% FBS. 
After 48 h, the media was collected and the concentration of 
L-lactate was measured. Results were normalized for total cell 
number.
Mitochondrial vital staining. Cells were seeded onto cover-
slips in 12-well plates in DMEM containing 10% FBS. After 
24 h, the media was change to DMEM supplemented with 
10% Nu-serum and 1% P/S. After 48 h, the mitochondria were 
labeled by incubating cells with a pre-warmed (37°C) staining 
solution containing the MitoTracker Red probe (25 nM for 12 
min at 37°C). Then, the cells were washed with PBS, fixed in 2% 
PFA and observed under a fluorescence microscope.
Ketone body production. Cells were seeded in 12-well plates 
in DMEM supplemented with 10% FBS. The next day, the 
media was switched to DMEM without red-phenol, contain-
ing 2% FBS. After 48 h, the media was collected, and the keto-
acid concentration was measured according the manufacturer’s 
instructions using the β-Hydroxy-butyrate (β-HB) Assay Kit 
(Biovision, #K632). Results were normalized for either total 
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Cellular hypertrophy assay. Approximately 100,000 cells were 
seeded per well in 12-well plates in DMEM containing 10% FBS. 
The next day, the media was switched to DMEM, supplemented 
with 10% Nu-serum. After 24 h, cells were counted and protein 
lysates were prepared with OG buffer. Protein quantification was 
performed using the BCA protein assay kit (Thermo scientific, 
#23225). The values were obtained were expressed as a ratio 
between the total amount of protein per well and the total num-
ber of cells per well (protein/cell number). An increased protein/
cell number ratio would be indicative of cellular hypertrophy.47
Animal studies. To evaluate the in vivo tumor promoting 
effects of autophagy-related genes, flank injections were per-
formed on athymic NCr nude mice (NCRNU; Taconic Farms; 
at 6–8 weeks of age). Experiments were performed according 
to the National Institutes of Health (NIH) guidelines, with the 
consensus of the Institutional Animal Care and Use Committee 
(IACUC) of Thomas Jefferson University. MDA-MB-231-GFP 
cells (alone or plus hTERT fibroblasts) were injected into the 
flanks of nude mice. More specifically, MDA-MB-231-GFP can-
cer cells (1 million cells) plus hTERT-BJ1 fibroblasts (300,000 
cell number or total cellular protein per well, depending on the 
experiment.
β-galactosidase flow-cytometry assay. Approximately 
400,000 cells were seeded per well in 6-well plates in DMEM 
with 10% FBS and 1% P/S. The next day, the media was changed 
to DMEM with 10% Nu-serum. Cells were then incubated for 
48 h at 37°C with 5% CO
2
, under normal conditions. Then, 
the cells were trypsinized, centrifuged and counted to obtain 106 
cells. Afterwards, cells were treated according the manufacturer’s 
instructions, using the FluoReporter lacZ Flow Cytometry Kit 
(Molecular probes, #F-1930). Assay results were evaluated by 
flow-cytometry analysis (FACS).
β-galactosidase staining assay. β-galactosidase activity was 
also detected by using a Senescence β-Galactosidase Staining 
Kit (Cell Signaling, #9860). For this purpose, cells were seeded 
into 6-well plates in complete media. After 24 h, the media was 
changed to DMEM supplemented with 10% Nu-serum. After 
48 h, the cells were fixed and incubated overnight at 37°C in 
a dry incubator without CO
2
, with the β-galactosidase staining 
solution. Afterwards, cells were observed under the microscope.
Table 1. Increased expression of autophagy markers and telomerase in the tumor stroma of human breast cancers
Gene stroma Description Tumor stroma Recurrence stroma Metastasis stroma
Atg16l1 autophagy-related 16-like 1 (yeast) 3.75E-15 1.64E-04
Atg9b ATG9 autophagy related 9 homolog B (S. cerevisiae) 1.97e-20 1.58e-03
Atg7 autophagy-related 7 (yeast) 7.64e-14
Atg4b autophagy-related 4B (yeast) 3.49e-05 2.75e-02
Atg4a autophagy-related 4A (yeast) 6.21e-03
Atg3 autophagy-related 3 (yeast) 1.01e-02 3.08e-03
Bnip3 BCL2/adenovirus E1B interacting protein 3 8.08E-03
Bnip3l BCL2/adenovirus E1B interacting protein 3-like 2.85E-08
Becn1 beclin 1, autophagy related 7.50E-05
Ctsb cathepsin B 4.11E-36 3.27E-02 1.39E-02
Ctsz cathepsin Z 5.62e-24
Ctsk cathepsin K 3.28e-20
Ctso cathepsin O 1.49e-19
Ctse cathepsin e 1.66e-19 3.78e-03
Ctss cathepsin S 3.70e-18
Ctsw cathepsin W 1.94e-15
Ctsf cathepsin F 7.03e-14
Ctsh cathepsin H 7.21e-12
Ctsg cathepsin G 1.32e-11 4.03e-04
Tert telomerase reverse transcriptase 1.34E-11 1.23E-02 2.17E-02
Tep1 telomerase associated protein 1 2.21e-07 5.05e-05
Rtel1 regulator of telomere elongation helicase 1 6.03e-06
Terf1 telomeric repeat binding factor 1 4.49e-02
Terf2 telomeric repeat binding factor 2 3.56e-08 1.63e-02
Data Mining from the Morag park Data Set: Finak et al. Nature Medicine 2008; 14:518–27. Certain key molecules are highlighted in BOLD, which we 
recombinantly overexpressed in human fibroblasts. p-values are as shown. 
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Table 2. Increased expression of CDK inhibitors and beta-gal (senescence markers) in the tumor stroma of human breast cancers
Gene stroma Description Tumor stroma Recurrence stroma Metastasis stroma
Cdkn1a cyclin-dependent kinase inhibitor 1A (p21, WAF/CIP1) 3.73E-19
Ciz1 CDKN1A interacting zinc finger protein 1 2.13e-02 4.59e-03
Cdkn1b cyclin-dependent kinase inhibitor 1B (p27, Kip1) 4.82e-02
Cdkn2a cyclin-dependent kinase inhibitor 2A (p16, INK4A) 5.71E-29
Cdkn2b cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 4.47e-07 9.38e-03
Cdkn2c cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) 1.04e-05
Cdkn3 cyclin-dependent kinase inhibitor 3 4.12e-02
Ccnb1 cyclin B1 1.53e-04 8.59e-03
Ccnd1 cyclin D1 1.42E-14 3.67E-02 4.21E-02
Glb1 galactosidase, beta1 1.91E-23
Data Mining from the Morag park Data Set: Finak et al. Nature Medicine 2008; 14:518–27. Certain key molecules are highlighted in BOLD, which we moni-
tored in autophagic fibroblasts overexpressing either BNIp3, CTSB or ATG16L1. p-values are as shown.
Figure 14. ATG16L1 expression in human breast cancer cells drives autophagy and reduces tumor growth. (A and B) To understand the compartment-
specific role of autophagy in tumor growth, we also stably overexpressed ATG16L1 in human breast cancer cells. ATG16L1 overexpression in MDA-MB 
231 cells by itself is indeed sufficient to drive autophagy and mitophagy under baseline cell culture conditions, as evidenced by the loss of Cav-1 
expression and the upregulation of BNIp3 (B). Similarly, MDA-MB 231 cells harboring ATG16L1 display the upregulation of certain autophagy markers 
(Beclin1 and CTSB), after overnight starvation (A). (C) Note that ATG16L1 overexpression in MDA-MB-213 cells induces p21 expression, but no significant 
changes were detected in p19 and/or Cyclin D1 protein levels. (D) We also assessed the capacity of autophagic MDA-MD-231 cells to undergo tumor 
growth in vivo, after implantation in the flanks of nude mice. Note that ATG16L1 overexpression caused a near 2-fold reduction in tumor volume. 
(e) However, we did not observe any differences in tumor neo-vascularization, as assessed by quantitation of CD31-positive vessels.
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cells) were re-suspended in 100 μl of sterile PBS, just prior to co-
injection into the flank. After 4 weeks post-injection, the tumors 
were collected, and tumor growth was quantitatively measured.
Experimental metastasis assay. To evaluate the functional 
effects of autophagic fibroblasts on distant metastasis, a lung 
colonization assay was performed. Briefly, MDA-MB-231-GFP 
breast cancer cells were co-injected with fibroblasts in the tail 
vein of athymic NCr nude mice (NCRNU; Taconic Farms; at 
6–8 weeks of age). More specifically, MDA-MB-231-GFP can-
cer cells (1 million cells) plus hTERT-BJ1 fibroblasts (300,000 
cells) were re-suspended in 100 μl of sterile PBS, just prior to co-
injection into the tail vein. After 7 weeks post-injection, the lungs 
were insuflated with 15% India ink dye, washed in water and 
bleached in Fekete’s solution (70% ethanol, 3.7% para-formalde-
hyde, 0.75 M glacial acetic acid). A low-power stereo-microscope 
was then used to determine the number of negatively stained 
metastatic colonies per lung lobe.
Quantitation of tumor angiogenesis. 6 μm tumor frozen sec-
tions were fixed with 4% paraformaldehyde in PBS for 10 min at 
4°C and washed 3x with PBS. A three-step biotin-streptavidin-
horseradish peroxidase method was used for antibody detection. 
After fixation, the sections were blocked with 10% rabbit serum 
and incubated overnight at 4°C with rat monoclonal CD31 
antibody (550274, BD Biosciences). The sections were then 
incubated with biotinylated rabbit anti-rat IgG (Vector Labs) 
and streptavidin-HRP (Dako). Immunoreactivity was revealed 
with 3,3'-diaminobenzidine. For quantitation of vessels, CD31-
positive vessels were counted in 8–10 fields within the central 
area of each tumor using a 20x objective lens and an ocular grid 
(0.25 mm2 per field). The total numbers of vessel per unit area 
was calculated, and the data was represented graphically.
Immunohistochemistry. Formalin-fixed paraffin-embedded 
tumor sections were de-paraffinized, rehydrated and washed in 
PBS. Antigen retrieval was performed in 10 mM sodium citrate, 
pH 6.0 for 10 min using a pressure cooker. After blocking with 
3% hydrogen peroxide for 10 min, sections were incubated with 
10% goat serum for 1 h. Then, sections were incubated with pri-
mary antibodies (anti-β-galactosidase: Abcam, #ab-96239, at 
a dilution of 1:1,000) overnight at 4°C. Antibody binding was 
detected using a biotinylated secondary (Vector Labs) followed 
by strepavidin-HRP (Dako). Immunoreactivity was revealed 
using 3,3'-diaminobenzidine. Finally, samples were counter-
stained with hematoxylin, dehydrated, mounted and observed 
under the microscope.
Bioinformatics analysis. The transcriptional profiles of tumor 
stroma isolated by laser-capture from human primary breast can-
cers,48 were retrieved and re-analyzed, essentially as we previously 
described.49
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Figure 15. Two-compartment tumor metabolism is fueled by the 
autophagy-senescence transition (AST). In this model, cancer cells 
secrete hydrogen peroxide (H2O2), which induces oxidative stress in 
neighboring normal fibroblasts. Oxidative stress in stromal fibroblasts 
is then sufficient to confer the cancer-associated fibroblast phenotype, 
resulting in autophagy, mitophagy and a shift toward aerobic glycoly-
sis. Autophagy also drives the onset of senescence via the autophagy-
senescence transition. Autophagic-senescent fibroblasts then produce 
high-energy nutrients (L-lactate, ketone bodies, glutamine and free 
fatty acids), which “fuel” mitochondrial metabolism (OXpHOS and β-OX; 
oxidative phosphorylation and β-oxidation) in adjacent cancer cells, 
resulting in the onset of anabolic tumor growth. This simple model 
could explain why chronological aging is one of the most significant 
risk factors for the development of cancer. AST, autophagy-senescence 
transition.
2300 Cell Cycle Volume 11 Issue 12
24. Krtolica A, Parrinello S, Lockett S, Desprez PY, 
Campisi J. Senescent fibroblasts promote epithelial 
cell growth and tumorigenesis: a link between cancer 
and aging. Proc Natl Acad Sci USA 2001; 98:12072-
7; PMID:11593017; http://dx.doi.org/10.1073/
pnas.211053698.
25. Krtolica A, Campisi J. Cancer and aging: a model 
for the cancer promoting effects of the aging stro-
ma. Int J Biochem Cell Biol 2002; 34:1401-14; 
PMID:12200035; http://dx.doi.org/10.1016/S1357-
2725(02)00053-5.
26. Coppé JP, Rodier F, Patil CK, Freund A, Desprez PY, 
Campisi J. Tumor suppressor and aging biomark-
er p16(INK4a) induces cellular senescence without 
the associated inflammatory secretory phenotype. J 
Biol Chem 2011; 286:36396-403; PMID:21880712; 
http://dx.doi.org/10.1074/jbc.M111.257071.
27. Young AR, Narita M. Connecting autophagy to 
senescence in pathophysiology. Curr Opin Cell Biol 
2010; 22:234-40; PMID:20045302; http://dx.doi.
org/10.1016/j.ceb.2009.12.005.
28. Narita M, Young AR, Narita M. Autophagy facili-
tates oncogene-induced senescence. Autophagy 
2009; 5:1046-7; PMID:19652542; http://dx.doi.
org/10.4161/auto.5.7.9444.
29. Tian LM, Xie HF, Xiao X, Yang T, Hu YH, Wang 
WZ, et al. Study on the roles of β-catenin in hydrogen 
peroxide-induced senescence in human skin fibroblasts. 
Exp Dermatol 2011; 20:836-8; PMID:21707762; 
http://dx.doi.org/10.1111/j.1600-0625.2011.01324.x.
30. Liu DH, Chen YM, Liu Y, Hao BS, Zhou B, Wu L, et 
al. Rb1 protects endothelial cells from hydrogen perox-
ide-induced cell senescence by modulating redox status. 
Biol Pharm Bull 2011; 34:1072-7; PMID:21720015; 
http://dx.doi.org/10.1248/bpb.34.1072.
31. Waghray M, Cui Z, Horowitz JC, Subramanian IM, 
Martinez FJ, Toews GB, et al. Hydrogen peroxide is a 
diffusible paracrine signal for the induction of epithelial 
cell death by activated myofibroblasts. FASEB J 2005; 
19:854-6; PMID:15857893.
32. Kurz DJ, Decary S, Hong Y, Erusalimsky JD. 
Senescence-associated (beta)-galactosidase reflects an 
increase in lysosomal mass during replicative ageing of 
human endothelial cells. J Cell Sci 2000; 113:3613-22; 
PMID:11017877.
33. Gerland LM, Peyrol S, Lallemand C, Branche R, 
Magaud JP, Ffrench M. Association of increased 
autophagic inclusions labeled for beta-galactosidase 
with fibroblastic aging. Exp Gerontol 2003; 38:887-95; 
PMID:12915210; http://dx.doi.org/10.1016/S0531-
5565(03)00132-3.
34. Robbins E, Levine EM, Eagle H. Morphologic changes 
accompanying senescence of cultured human diploid 
cells. J Exp Med 1970; 131:1211-22; PMID:5419270; 
http://dx.doi.org/10.1084/jem.131.6.1211.
35. Stöckl P, Hütter E, Zwerschke W, Jansen-Dürr P. 
Sustained inhibition of oxidative phosphoryla-
tion impairs cell proliferation and induces prema-
ture senescence in human fibroblasts. Exp Gerontol 
2006; 41:674-82; PMID:16713693; http://dx.doi.
org/10.1016/j.exger.2006.04.009.
36. Goldstein S, Ballantyne SR, Robson AL, Moerman 
EJ. Energy metabolism in cultured human fibroblasts 
during aging in vitro. J Cell Physiol 1982; 112:419-
24; PMID:6127343; http://dx.doi.org/10.1002/
jcp.1041120316.
37. Lee BY, Han JA, Im JS, Morrone A, Johung K, 
Goodwin EC, et al. Senescence-associated beta-galac-
tosidase is lysosomal beta-galactosidase. Aging Cell 
2006; 5:187-95; PMID:16626397; http://dx.doi.
org/10.1111/j.1474-9726.2006.00199.x.
38. White E, Lowe SW. Eating to exit: autophagy-enabled 
senescence revealed. Genes Dev 2009; 23:784-
7; PMID:19339684; http://dx.doi.org/10.1101/
gad.1795309.
39. Chen J, Goligorsky MS. Premature senescence of endo-
thelial cells: Methusaleh’s dilemma. Am J Physiol Heart 
Circ Physiol 2006; 290:1729-39; PMID:16603702; 
http://dx.doi.org/10.1152/ajpheart.01103.2005.
12. Martinez-Outschoorn UE, Whitaker-Menezes D, 
Pavlides S, Chiavarina B, Bonuccelli G, Casey T, et 
al. The autophagic tumor stroma model of cancer or 
“battery-operated tumor growth”: A simple solution 
to the autophagy paradox. Cell Cycle 2010; 9:4297-
306; PMID:21051947; http://dx.doi.org/10.4161/
cc.9.21.13817.
13. Martinez-Outschoorn UE, Pavlides S, Howell A, 
Pestell RG, Tanowitz HB, Sotgia F, et al. Stromal-
epithelial metabolic coupling in cancer: integrating 
autophagy and metabolism in the tumor microenvi-
ronment. Int J Biochem Cell Biol 2011; 43:1045-51; 
PMID:21300172; http://dx.doi.org/10.1016/j.bio-
cel.2011.01.023.
14. Ertel A, Tsirigos A, Whitaker-Menezes D, Birbe RC, 
Pavlides S, Martinez-Outschoorn UE, et al. Is cancer 
a metabolic rebellion against host aging? In the quest 
for immortality, tumor cells try to save themselves 
by boosting mitochondrial metabolism. Cell Cycle 
2012; 11:253-63; PMID:22234241; http://dx.doi.
org/10.4161/cc.11.2.19006.
15. Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier 
I, Wang C, Bonuccelli G, et al. Towards a new 
“stromal-based” classification system for human breast 
cancer prognosis and therapy. Cell Cycle 2009; 8:1654-
8; PMID:19448435; http://dx.doi.org/10.4161/
cc.8.11.8544.
16. Witkiewicz AK, Dasgupta A, Nguyen KH, Liu C, 
Kovatich AJ, Schwartz GF, et al. Stromal caveo-
lin-1 levels predict early DCIS progression to inva-
sive breast cancer. Cancer Biol Ther 2009; 8:1071-
9; PMID:19502809; http://dx.doi.org/10.4161/
cbt.8.11.8874.
17. Witkiewicz AK, Dasgupta A, Sammons S, Er O, 
Potoczek MB, Guiles F, et al. Loss of stromal caveo-
lin-1 expression predicts poor clinical outcome in 
triple negative and basal-like breast cancers. Cancer 
Biol Ther 2010; 10:135-43; PMID:20431349; http://
dx.doi.org/10.4161/cbt.10.2.11983.
18. Witkiewicz AK, Dasgupta A, Sotgia F, Mercier I, Pestell 
RG, Sabel M, et al. An absence of stromal caveolin-1 
expression predicts early tumor recurrence and poor 
clinical outcome in human breast cancers. Am J Pathol 
2009; 174:2023-34; PMID:19411448; http://dx.doi.
org/10.2353/ajpath.2009.080873.
19. Witkiewicz AK, Kline J, Queenan M, Brody JR, 
Tsirigos A, Bilal E, et al. Molecular profiling of a 
lethal tumor microenvironment, as defined by stro-
mal caveolin-1 status in breast cancers. Cell Cycle 
2011; 10:1794-809; PMID:21521946; http://dx.doi.
org/10.4161/cc.10.11.15675.
20. Witkiewicz AK, Whitaker-Menezes D, Dasgupta A, 
Philp NJ, Lin Z, Gandara R, et al. Using the “reverse 
Warburg effect” to identify high-risk breast cancer 
patients: stromal MCT4 predicts poor clinical out-
come in triple-negative breast cancers. Cell Cycle 
2012; 11:1108-17; PMID:22313602; http://dx.doi.
org/10.4161/cc.11.6.19530.
21. Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman 
MR, Lisanti MP. An absence of stromal caveolin-1 
is associated with advanced prostate cancer, meta-
static disease and epithelial Akt activation. Cell Cycle 
2009; 8:2420-4; PMID:19556867; http://dx.doi.
org/10.4161/cc.8.15.9116.
22. Wu KN, Queenan M, Brody JR, Potoczek M, Sotgia F, 
Lisanti MP, et al. Loss of stromal caveolin-1 expression 
in malignant melanoma metastases predicts poor sur-
vival. Cell Cycle 2011; 10:4250-5; PMID:22134245; 
http://dx.doi.org/10.4161/cc.10.24.18551.
23. Chiavarina B, Whitaker-Menezes D, Migneco G, 
Martinez-Outschoorn UE, Pavlides S, Howell A, et 
al. HIF1-alpha functions as a tumor promoter in 
cancer-associated fibroblasts, and as a tumor suppres-
sor in breast cancer cells: Autophagy drives compart-
ment-specific oncogenesis. Cell Cycle 2010; 9:3534-
51; PMID:20864819; http://dx.doi.org/10.4161/
cc.9.17.12908.
References
1. Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell 
RG, Pavlides S, Lisanti MP. Caveolin-1 and can-
cer metabolism in the tumor microenvironment: 
markers, models and mechanisms. Annu Rev Pathol 
2012; 7:423-67; PMID:22077552; http://dx.doi.
org/10.1146/annurev-pathol-011811-120856.
2. Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Power 
surge: supporting cells “fuel” cancer cell mitochondria. 
Cell Metab 2012; 15:4-5; PMID:22225869; http://
dx.doi.org/10.1016/j.cmet.2011.12.011.
3. Lisanti MP, Martinez-Outschoorn UE, Lin Z, Pavlides 
S, Whitaker-Menezes D, Pestell RG, et al. Hydrogen 
peroxide fuels aging, inflammation, cancer metabolism 
and metastasis: the seed and soil also needs “fertilizer”. 
Cell Cycle 2011; 10:2440-9; PMID:21734470; http://
dx.doi.org/10.4161/cc.10.15.16870.
4. Lisanti MP, Martinez-Outschoorn UE, Pavlides 
S, Whitaker-Menezes D, Pestell RG, Howell A, et 
al. Accelerated aging in the tumor microenviron-
ment: connecting aging, inflammation and cancer 
metabolism with personalized medicine. Cell Cycle 
2011; 10:2059-63; PMID:21654190; http://dx.doi.
org/10.4161/cc.10.13.16233.
5. Martinez-Outschoorn UE, Balliet RM, Rivadeneira 
DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative 
stress in cancer-associated fibroblasts drives tumor-
stroma co-evolution: A new paradigm for understand-
ing tumor metabolism, the field effect and genomic 
instability in cancer cells. Cell Cycle 2010; 9:3256-
76; PMID:20814239; http://dx.doi.org/10.4161/
cc.9.16.12553.
6. Martinez-Outschoorn UE, Trimmer C, Lin Z, 
Whitaker-Menezes D, Chiavarina B, Zhou J, et 
al. Autophagy in cancer-associated fibroblasts pro-
motes tumor cell survival: Role of hypoxia, HIF1 
induction and NFκB activation in the tumor stro-
mal microenvironment. Cell Cycle 2010; 9:3515-
33; PMID:20855962; http://dx.doi.org/10.4161/
cc.9.17.12928.
7. Martinez-Outschoorn UE, Pestell RG, Howell A, 
Tykocinski ML, Nagajyothi F, Machado FS, et al. 
Energy transfer in “parasitic” cancer metabolism: mito-
chondria are the powerhouse and Achilles’ heel of tumor 
cells. Cell Cycle 2011; 10:4208-16; PMID:22033146; 
http://dx.doi.org/10.4161/cc.10.24.18487.
8. Sotgia F, Martinez-Outschoorn UE, Pavlides S, Howell 
A, Pestell RG, Lisanti MP. Understanding the Warburg 
effect and the prognostic value of stromal caveolin-1 as 
a marker of a lethal tumor microenvironment. Breast 
Cancer Res 2011; 13:213; PMID:21867571; http://
dx.doi.org/10.1186/bcr2892.
9. Whitaker-Menezes D, Martinez-Outschoorn UE, 
Flomenberg N, Birbe RC, Witkiewicz AK, Howell 
A, et al. Hyperactivation of oxidative mitochondrial 
metabolism in epithelial cancer cells in situ: visualizing 
the therapeutic effects of metformin in tumor tis-
sue. Cell Cycle 2011; 10:4047-64; PMID:22134189; 
http://dx.doi.org/10.4161/cc.10.23.18151.
10. Sotgia F, Whitaker-Menezes D, Martinez-Outschoorn 
UE, Flomenberg N, Birbe RC, Witkiewicz AK, et 
al. Mitochondrial metabolism in cancer metastasis: 
visualizing tumor cell mitochondria and the “reverse 
Warburg effect” in positive lymph node tissue. Cell 
Cycle 2012; 11:1445-54; PMID:22395432; http://
dx.doi.org/10.4161/cc.19841.
11. Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes 
D, Chiavarina B, Flomenberg N, et al. The autophagic 
tumor stroma model of cancer: Role of oxidative stress 
and ketone production in fueling tumor cell metabo-
lism. Cell Cycle 2010; 9:3485-505; PMID:20861672; 
http://dx.doi.org/10.4161/cc.9.17.12721.
www.landesbioscience.com Cell Cycle 2301
69. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, 
Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes 
promote ovarian cancer metastasis and provide energy 
for rapid tumor growth. Nat Med 2011; 17:1498-
503; PMID:22037646; http://dx.doi.org/10.1038/
nm.2492.
70. Martinez-Outschoorn UE, Lin Z, Trimmer C, 
Flomenberg N, Wang C, Pavlides S, et al. Cancer cells 
metabolically “fertilize” the tumor microenvironment 
with hydrogen peroxide, driving the Warburg effect: 
implications for PET imaging of human tumors. Cell 
Cycle 2011; 10:2504-20; PMID:21778829; http://
dx.doi.org/10.4161/cc.10.15.16585.
71. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank 
PG, Casimiro MC, et al. Loss of stromal caveo-
lin-1 leads to oxidative stress, mimics hypoxia and 
drives inflammation in the tumor microenvironment, 
conferring the “reverse Warburg effect”: a transcrip-
tional informatics analysis with validation. Cell Cycle 
2010; 9:2201-19; PMID:20519932; http://dx.doi.
org/10.4161/cc.9.11.11848.
72. Pavlides S, Vera I, Gandara R, Sneddon S, Pestell RG, 
Mercier I, et al. Warburg Meets Autophagy: Cancer-
Associated Fibroblasts Accelerate Tumor Growth and 
Metastasis via Oxidative Stress, Mitophagy and Aerobic 
Glycolysis. Antioxid Redox Signal 2011; 16: 1264-84; 
PMID:21883043.
73. Pavlides S, Whitaker-Menezes D, Castello-Cros R, 
Flomenberg N, Witkiewicz AK, Frank PG, et al. The 
reverse Warburg effect: aerobic glycolysis in cancer-
associated fibroblasts and the tumor stroma. Cell Cycle 
2009; 8:3984-4001; PMID:19923890; http://dx.doi.
org/10.4161/cc.8.23.10238.
74. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, Pavlides 
S, Pestell RG, Chiavarina B, et al. Ketones and lactate 
“fuel” tumor growth and metastasis: Evidence that epi-
thelial cancer cells use oxidative mitochondrial metabo-
lism. Cell Cycle 2010; 9:3506-14; PMID:20818174; 
http://dx.doi.org/10.4161/cc.9.17.12731.
75. Martinez-Outschoorn UE, Prisco M, Ertel A, Tsirigos 
A, Lin Z, Pavlides S, et al. Ketones and lactate increase 
cancer cell “stemness,” driving recurrence, metastasis 
and poor clinical outcome in breast cancer: achieving 
personalized medicine via Metabolo-Genomics. Cell 
Cycle 2011; 10:1271-86; PMID:21512313; http://
dx.doi.org/10.4161/cc.10.8.15330.
76. Whitaker-Menezes D, Martinez-Outschoorn UE, 
Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, et 
al. Evidence for a stromal-epithelial “lactate shuttle” 
in human tumors: MCT4 is a marker of oxida-
tive stress in cancer-associated fibroblasts. Cell Cycle 
2011; 10:1772-83; PMID:21558814; http://dx.doi.
org/10.4161/cc.10.11.15659.
77. Cahill GF Jr, Veech RL. Ketoacids? Good medicine? 
Trans Am Clin Climatol Assoc 2003; 114:149-61; 
PMID:12813917.
78. Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill 
GF Jr. Ketone bodies, potential therapeutic uses. 
IUBMB Life 2001; 51:241-7; PMID:11569918; 
http://dx.doi.org/10.1080/152165401753311780.
79. McPherson PA, McEneny J. The biochemistry of 
ketogenesis and its role in weight management, neuro-
logical disease and oxidative stress. J Physiol Biochem 
2012; 68:141-51; PMID:21983804; http://dx.doi.
org/10.1007/s13105-011-0112-4.
80. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin 
JR, Hux JE. The impact of diabetes on survival 
following breast cancer. Breast Cancer Res Treat 
2008; 109:389-95; PMID:17659440; http://dx.doi.
org/10.1007/s10549-007-9654-0.
81. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, 
Derr RL, et al. Long-term all-cause mortality in cancer 
patients with preexisting diabetes mellitus: a system-
atic review and meta-analysis. JAMA 2008; 300:2754-
64; PMID:19088353; http://dx.doi.org/10.1001/
jama.2008.824.
54. Ha SD, Ham B, Mogridge J, Saftig P, Lin S, Kim 
SO. Cathepsin B-mediated autophagy flux facilitates 
the anthrax toxin receptor 2-mediated delivery of 
anthrax lethal factor into the cytoplasm. J Biol Chem 
2010; 285:2120-9; PMID:19858192; http://dx.doi.
org/10.1074/jbc.M109.065813.
55. Mizushima N, Kuma A, Kobayashi Y, Yamamoto A, 
Matsubae M, Takao T, et al. Mouse Apg16L, a novel 
WD-repeat protein, targets to the autophagic isolation 
membrane with the Apg12-Apg5 conjugate. J Cell Sci 
2003; 116:1679-88; PMID:12665549; http://dx.doi.
org/10.1242/jcs.00381.
56. Ravikumar B, Moreau K, Rubinsztein DC. Plasma 
membrane helps autophagosomes grow. Autophagy 
2010; 6:1184-6; PMID:20861674; http://dx.doi.
org/10.4161/auto.6.8.13428.
57. Ravikumar B, Moreau K, Jahreiss L, Puri C, 
Rubinsztein DC. Plasma membrane contributes to 
the formation of pre-autophagosomal structures. Nat 
Cell Biol 2010; 12:747-57; PMID:20639872; http://
dx.doi.org/10.1038/ncb2078.
58. Goldman SJ, Taylor R, Zhang Y, Jin S. Autophagy 
and the degradation of mitochondria. Mitochondrion 
2010; 10:309-15; PMID:20083234; http://dx.doi.
org/10.1016/j.mito.2010.01.005.
59. Yamashita M, Ogawa T, Zhang X, Hanamura N, 
Kashikura Y, Takamura M, et al. Role of stromal 
myofibroblasts in invasive breast cancer: stromal expres-
sion of alpha-smooth muscle actin correlates with 
worse clinical outcome. Breast Cancer 2012; 19:170-6; 
PMID:20978953; http://dx.doi.org/10.1007/s12282-
010-0234-5.
60. Nomura H, Uzawa K, Yamano Y, Fushimi K, Ishigami 
T, Kouzu Y, et al. Overexpression and altered subcel-
lular localization of autophagy-related 16-like 1 in 
human oral squamous-cell carcinoma: correlation with 
lymphovascular invasion and lymph-node metasta-
sis. Hum Pathol 2009; 40:83-91; PMID:18789482; 
http://dx.doi.org/10.1016/j.humpath.2008.06.018.
61. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie 
M, Darot JF, et al. Autophagy mediates the mitot-
ic senescence transition. Genes Dev 2009; 23:798-
803; PMID:19279323; http://dx.doi.org/10.1101/
gad.519709.
62. Narita M, Young AR, Arakawa S, Samarajiwa SA, 
Nakashima T, Yoshida S, et al. Spatial coupling of 
mTOR and autophagy augments secretory phenotypes. 
Science 2011; 332:966-70; PMID:21512002; http://
dx.doi.org/10.1126/science.1205407.
63. Zoncu R, Sabatini DM. Cell biology. The TASCC of 
secretion. Science 2011; 332:923-5; PMID:21596981; 
http://dx.doi.org/10.1126/science.1207552.
64. Aita VM, Liang XH, Murty VV, Pincus DL, Yu 
W, Cayanis E, et al. Cloning and genomic organi-
zation of beclin 1, a candidate tumor suppressor 
gene on chromosome 17q21. Genomics 1999; 59:59-
65; PMID:10395800; http://dx.doi.org/10.1006/
geno.1999.5851.
65. Liang XH, Jackson S, Seaman M, Brown K, Kempkes 
B, Hibshoosh H, et al. Induction of autophagy and 
inhibition of tumorigenesis by beclin 1. Nature 
1999; 402:672-6; PMID:10604474; http://dx.doi.
org/10.1038/45257.
66. Mariño G, Salvador-Montoliu N, Fueyo A, Knecht 
E, Mizushima N, López-Otín C. Tissue-specific 
autophagy alterations and increased tumorigenesis in 
mice deficient in Atg4C/autophagin-3. J Biol Chem 
2007; 282:18573-83; PMID:17442669; http://dx.doi.
org/10.1074/jbc.M701194200.
67. Scherz-Shouval R, Elazar Z. ROS, mitochondria 
and the regulation of autophagy. Trends Cell Biol 
2007; 17:422-7; PMID:17804237; http://dx.doi.
org/10.1016/j.tcb.2007.07.009.
68. Maiuri MC, Tasdemir E, Criollo A, Morselli E, 
Vicencio JM, Carnuccio R, et al. Control of autophagy 
by oncogenes and tumor suppressor genes. Cell Death 
Differ 2009; 16:87-93; PMID:18806760; http://
dx.doi.org/10.1038/cdd.2008.131.
40. Sasaki M, Ikeda H, Yamaguchi J, Miyakoshi M, Sato 
Y, Nakanuma Y. Bile ductular cells undergoing cellular 
senescence increase in chronic liver diseases along with 
fibrous progression. Am J Clin Pathol 2010; 133:212-
23; PMID:20093230; http://dx.doi.org/10.1309/
AJCPWMX47TREYWZG.
41. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. 
Autophagy mediates the process of cellular senescence 
characterizing bile duct damages in primary biliary cir-
rhosis. Lab Invest 2010; 90:835-43; PMID:20212459; 
http://dx.doi.org/10.1038/labinvest.2010.56.
42. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. 
Modulation of the microenvironment by senescent bili-
ary epithelial cells may be involved in the pathogenesis 
of primary biliary cirrhosis. J Hepatol 2010; 53:318-
25; PMID:20570384; http://dx.doi.org/10.1016/j.
jhep.2010.03.008.
43. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. 
Autophagy may precede cellular senescence of bile 
ductular cells in ductular reaction in primary biliary cir-
rhosis. Dig Dis Sci 2012; 57:660-6; PMID:21989821; 
http://dx.doi.org/10.1007/s10620-011-1929-y.
44. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y. A 
possible involvement of p62/sequestosome-1 in the 
process of biliary epithelial autophagy and senescence 
in primary biliary cirrhosis. Liver Int 2012; 32:487-99; 
PMID:22098537.
45. Chatzistamou I, Dioufa N, Trimis G, Sklavounou A, 
Kittas C, Kiaris H, et al. p21/waf1 and smooth-muscle 
actin-α expression in stromal fibroblasts of oral cancers. 
Cell Oncol (Dordr) 2011; 34:483-8; PMID:21559927; 
http://dx.doi.org/10.1007/s13402-011-0044-6.
46. Luo Y, Zou P, Zou J, Wang J, Zhou D, Liu L. 
Autophagy regulates ROS-induced cellular senescence 
via p21 in a p38 MAPKα dependent manner. Exp 
Gerontol 2011; 46:860-7; PMID:21816217; http://
dx.doi.org/10.1016/j.exger.2011.07.005.
47. Demidenko ZN, Blagosklonny MV. Quantifying phar-
macologic suppression of cellular senescence: pre-
vention of cellular hypertrophy versus preservation 
of proliferative potential. Aging (Albany NY) 2009; 
1:1008-16; PMID:20157583.
48. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova 
M, Zhao H, et al. Stromal gene expression pre-
dicts clinical outcome in breast cancer. Nat Med 
2008; 14:518-27; PMID:18438415; http://dx.doi.
org/10.1038/nm1764.
49. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank 
PG, Casimiro MC, et al. Transcriptional evidence for 
the “Reverse Warburg Effect” in human breast cancer 
tumor stroma and metastasis: similarities with oxidative 
stress, inflammation, Alzheimer’s disease and “Neuron-
Glia Metabolic Coupling”. Aging (Albany NY) 2010; 
2:185-99; PMID:20442453.
50. Chinnadurai G, Vijayalingam S, Gibson SB. BNIP3 
subfamily BH3-only proteins: mitochondrial stress sen-
sors in normal and pathological functions. Oncogene 
2008; 27:114-27; PMID:19641497; http://dx.doi.
org/10.1038/onc.2009.49.
51. Martinez-Outschoorn UE, Pavlides S, Whitaker-
Menezes D, Daumer KM, Milliman JN, Chiavarina B, 
et al. Tumor cells induce the cancer-associated fibroblast 
phenotype via caveolin-1 degradation: implications for 
breast cancer and DCIS therapy with autophagy inhibi-
tors. Cell Cycle 2010; 9:2423-33; PMID:20562526; 
http://dx.doi.org/10.4161/cc.9.12.12048.
52. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux 
D, Pouysségur J, et al. Hypoxia-induced autophagy is 
mediated through hypoxia-inducible factor induction 
of BNIP3 and BNIP3L via their BH3 domains. Mol 
Cell Biol 2009; 29:2570-81; PMID:19273585; http://
dx.doi.org/10.1128/MCB.00166-09.
53. Mazure NM, Pouysségur J. Atypical BH3-domains of 
BNIP3 and BNIP3L lead to autophagy in hypoxia. 
Autophagy 2009; 5:868-9; PMID:19587545.
2302 Cell Cycle Volume 11 Issue 12
82. Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert 
G. Metastatic breast cancer: clinical course, prognosis 
and therapy related to the first site of metastasis. Breast 
Cancer Res Treat 2000; 59:271-8; PMID:10832597; 
http://dx.doi.org/10.1023/A:1006308619659.
83. Chen J, Xavier S, Moskowitz-Kassai E, Chen R, Lu 
CY, Sanduski K, et al. Cathepsin cleavage of sirtuin 1 
in endothelial progenitor cells mediates stress-induced 
premature senescence. Am J Pathol 2012; 180:973-
83; PMID:22234173; http://dx.doi.org/10.1016/j.
ajpath.2011.11.033.
84. Blagosklonny MV, Campisi J, Sinclair DA. Aging: past, 
present and future. Aging (Albany NY) 2009; 1:1-5; 
PMID:20157590.
